Introduction
Cimetidine, a specific histamine-2 receptor antagonist, is widely used in the treatment of peptic ulcer, and side effects, such as diarrhoea, muscular pain, rash and dizziness are relatively uncommon. Confusion is rare but has been described in elderly patients, usually with underlying renal or liver impairment. We are not aware of any reported cases of an extrapyramidal and cerebellar syndrome with an acute encephalopathy due to cimetidine and we report a possible case, since it gave rise to diagnostic difficulty. Case 
Clinical reports
Madopar '125' (levodopa and benserazide) three times daily but remained markedly confused. Thirtythree days after admission the cimetidine was stopped. His mental state rapidly improved and over the next three weeks the tremor resolved and the rigidity slowly improved. The Madopar was discontinued and the patient's mobility increased.
Discussion
This patient developed an acute confusional state, visual hallucinations, twitching, cerebellar and extrapyramidal signs about 3 weeks after starting cimetidine in recommended oral dosage. He had no renal or hepatic impairment. Because of his known cerebrovascular disease, multi-infarct dementia may have caused the acute confusional state and possibly the extrapyramidal signs. There was, however, no evidence of hypovolaemic shock or hypoxia associated with his haematemesis. The acute onset of the widespread progressive neurological features nearly 3 weeks after the haematemesis, together with their resolution imply a cimetidine associated encephalopathy as the more likely explanation of the patient's illness. His improvement was sustained on stopping the anti-Parkinson's medication. In view of the severity of the neurological disturbance which responded to withdrawal of the cimetidine, we thought it clinically inappropriate to rechallenge him with the drug. The initial haematemesis may have been related to the prolonged aspirin ingestion.
Earlier reported cases have incriminated cimetidine as causing mental confusion (Grimson, 1977; Wood, Isaacson and Hibbs, 1978) , visual hallucinations (Agarwal, 1978) , and brain stem dysfunction (Cumming and Foster, 1978) , usually within a few days of starting treatment. In some of these cases, however, other medical conditions existed which may have been contributory. A recent paper (Sonnenblick, Rosin and Weissberg, 1982) reviewed the neurological and psychiatric side effects of cimetidine. Mental confusion was present in over half the reviewed cases but reversible extrapyramidal and cerebellar features are not recorded.
Cimetidine has been found in the cerebro-spinal fluid of patients with presumed normal meninges as well as those in whom the blood-brain-barrier has become more permeable due to meningitis or renal failure and it may therefore have a central action (Edmonds et al., 1979) . It has been suggested that cimetidine blocks histamine-2 receptors in the central nervous system and this is endorsed in animal experiments. Because of the extrapyramidal features displayed in our patient, cimetidine may also have effects on acetylcholine and dopaminergic receptors in the brain.
We conclude that cimetidine must be used with great care in the elderly, especially those with known cerebrovascular disease and renal or hepatic impairment. Neuropsychiatric side effects may occur, even in recommended doses, and so a reduced dose of the drug should be given to those patients who are at risk from these complications. 
